Advertisement
EVGN vs NCNA
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVGN is a Hold and NCNA is a Hold.
EVGN in upward trend: price expected to rise as it breaks its lower Bollinger Band on November 05, 2026
EVGN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 36 of 45 cases where EVGN's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 80%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where EVGN's RSI Indicator exited the oversold zone, 34 of 45 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 54 of 74 cases where EVGN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 73%.
The Momentum Indicator moved above the 0 level on November 10, 2026. You may want to consider a long position or call options on EVGN as a result. In 67 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 75%.
Following a +37.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where EVGN advanced for three days, in 141 of 197 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for EVGN turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 43 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EVGN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for EVGN entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 27 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-1.302) is normal, around the industry mean (3.498). P/E Ratio (-0.366) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (3.012) is also within normal values, averaging (440.869).
The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. EVGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EVGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
NCNA's RSI Indicator ascends from oversold territory
The RSI Indicator for NCNA moved out of oversold territory on October 23, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 36 similar instances when the indicator left oversold territory. In 34 of the 36 cases the stock moved higher. This puts the odds of a move higher at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for NCNA just turned positive on October 26, 2026. Looking at past instances where NCNA's MACD turned positive, the stock continued to rise in 27 of 37 cases over the following month. The odds of a continued upward trend are 73%.
Following a +2.86% 3-day Advance, the price is estimated to grow further. Considering data from situations where NCNA advanced for three days, in 158 of 204 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NCNA as a result. In 86 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NCNA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for NCNA entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 5 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 51 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.194) is normal, around the industry mean (3.498). P/E Ratio (0.019) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).
The Tickeron Price Growth Rating for this company is 84 (best 1 - 100 worst), indicating slightly worse than average price growth. NCNA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NCNA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
EVGN | NCNA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 45 | 2 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 27 Undervalued | 51 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 98 | |
PRICE GROWTH RATING 1..100 | 91 | 84 | |
P/E GROWTH RATING 1..100 | 9 | 5 | |
SEASONALITY SCORE 1..100 | 45 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
EVGN's Valuation (27) in the Biotechnology industry is in the same range as NCNA (51). This means that EVGN’s stock grew similarly to NCNA’s over the last 12 months.
EVGN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as NCNA (100). This means that EVGN’s stock grew similarly to NCNA’s over the last 12 months.
NCNA's SMR Rating (98) in the Biotechnology industry is in the same range as EVGN (100). This means that NCNA’s stock grew similarly to EVGN’s over the last 12 months.
NCNA's Price Growth Rating (84) in the Biotechnology industry is in the same range as EVGN (91). This means that NCNA’s stock grew similarly to EVGN’s over the last 12 months.
NCNA's P/E Growth Rating (5) in the Biotechnology industry is in the same range as EVGN (9). This means that NCNA’s stock grew similarly to EVGN’s over the last 12 months.
| EVGN | NCNA | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 76% | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 73% | 2 days ago 85% |
| Momentum ODDS (%) | 2 days ago 75% | 2 days ago 90% |
| MACD ODDS (%) | 2 days ago 90% | 2 days ago 73% |
| TrendWeek ODDS (%) | 2 days ago 75% | 2 days ago 90% |
| TrendMonth ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Advances ODDS (%) | 2 days ago 72% | 3 days ago 77% |
| Declines ODDS (%) | 6 days ago 90% | 21 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 80% | N/A |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 88% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
EVGN’s FA Score shows that 2 FA rating(s) are green while NCNA’s FA Score has 1 green FA rating(s).
- EVGN’s FA Score: 2 green, 3 red.
- NCNA’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
EVGN’s TA Score shows that 5 TA indicator(s) are bullish while NCNA’s TA Score has 4 bullish TA indicator(s).
- EVGN’s TA Score: 5 bullish, 3 bearish.
- NCNA’s TA Score: 4 bullish, 3 bearish.
Price Growth
EVGN (@Biotechnology) experienced а +5.89% price change this week, while NCNA (@Biotechnology) price change was -6.22% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was -2.72%, and the average quarterly price growth was -13.41%.
Reported Earning Dates
EVGN is expected to report earnings on Nov 19, 2026.
NCNA is expected to report earnings on Nov 12, 2026.
Industries' Descriptions
@Biotechnology (+4.90% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
NCNA and
Correlation & Price change
A.I.dvisor indicates that over the last year, NCNA has been closely correlated with TAOX. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if NCNA jumps, then TAOX could also see price increases.
| Ticker / NAME | Correlation To NCNA | 1D Price Change % | ||
|---|---|---|---|---|
| NCNA | 100% | -2.38% | ||
| TAOX - NCNA | 92% Closely correlated | -5.15% | ||
| PALI - NCNA | 81% Closely correlated | -5.04% | ||
| PLX - NCNA | 34% Loosely correlated | +11.28% | ||
| INMB - NCNA | 34% Loosely correlated | -2.65% | ||
| IOVA - NCNA | 34% Loosely correlated | -1.10% | ||
More | ||||